1.31 USD
-0.010.00%
盘后 1.31 0.00%
2026-08-03
市值
$977.69M
市盈率
—
EPS
-0.09
股息率
—
52 周区间
0.98 – 1.73
成交量
3.71M
Beta
1.49
目标价
4.38
52W 低 0.9852W 高 1.73
价格走势
公司简介
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune syst...